Drug: rituximab Quarter: 2016Q3
Total Records: 1,104 Number of Pages: 56
| DRUGNAME | PT | EventCount |
|---|---|---|
| RITUXIMAB | Lung squamous cell carcinoma stage IV | 2 |
| RITUXIMAB | Malignant melanoma | 2 |
| rituximab | Melaena | 2 |
| RITUXIMAB | Meningitis cryptococcal | 2 |
| Rituximab | Meniscal degeneration | 2 |
| Rituximab | Mental status changes | 2 |
| RITUXIMAB | Mesenteric vascular occlusion | 2 |
| Rituximab | Metastases to meninges | 2 |
| rituximab | Microsporidia infection | 2 |
| rituximab | Myoclonus | 2 |
| Rituximab | Nasopharyngitis | 2 |
| RITUXIMAB | Nephropathy toxic | 2 |
| RITUXIMAB | Neurological decompensation | 2 |
| Rituximab | Neurotoxicity | 2 |
| Rituximab | Neutrophilia | 2 |
| Rituximab | Oesophageal atresia | 2 |
| Rituximab | Overdose | 2 |
| Rituximab | Oxygen saturation decreased | 2 |
| Rituximab | Parainfluenzae virus infection | 2 |
| Rituximab | Pelvic fracture | 2 |
Total Records: 1,104 Number of Pages: 56